ArticlePloS one2020

Restricting extracellular Ca2+ on gefitinib-resistant non-small cell lung cancer cells reverses altered epidermal growth factor-mediated Ca2+ response, which consequently enhances gefitinib sensitivity.

Mi Seong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.